CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control (scientific article published in Scientific Reports)

Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization

Q24655389

Emerging strategies to deplete the HIV reservoir

Q27023877

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Q28253761

Fcgamma receptors as regulators of immune responses

Q29615584

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Q29615993

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

Q29619611

IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.

Q33210552

Th17 cells and regulatory T cells in elite control over HIV and SIV.

Q33838915

Th17 cells are long lived and retain a stem cell-like molecular signature

Q34241261

Activation-Dependent Expression of Low Affinity IgG Receptors FcγRII(CD32) and FcγRIII(CD16) in Subpopulations of Human T Lymphocytes

Q34303223

Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells

Q34594969

Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies

Q34607763

HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

Q34672568

Interleukin 7 up-regulates CD95 protein on CD4+ T cells by affecting mRNA alternative splicing: priming for a synergistic effect on HIV-1 reservoir maintenance

Q34801476

Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth

Q35944804

Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients

Q36102514

The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance

Q36133008

Interleukin 7 regulates the survival and generation of memory CD4 cells

Q36371578

HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells

Q36428308

Measuring the latent reservoir in vivo.

Q36515110

Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.

Q36736667

Interleukin-7 promotes HIV persistence during antiretroviral therapy

Q36873277

Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy

Q36957851

High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.

Q37123276

The majority of HIV type 1 DNA in circulating CD4+ T lymphocytes is present in non-gut-homing resting memory CD4+ T cells

Q37204158

Cd32 Expression of Different Memory T Cell Subpopulations in the Blood and Lymph Nodal Tissue of Hiv Patients and Healthy Controls Correlates with Immune Activation.

Q50543053

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Q52007779

CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.

Q53822439

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA.

Q54204987

CD32 and PD-1 Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals

Q57469955

HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy

Q37461290

HIV-1 Reservoirs During Suppressive Therapy

Q37656766

Towards an HIV-1 cure: measuring the latent reservoir

Q38369541

Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents?

Q38773858

Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications

Q38936786

CCR6/CCL20 chemokine axis in human immunodeficiency virus immunity and pathogenesis

Q39049373

Diagnostic utility of droplet digital PCR for HIV reservoir quantification

Q39534580

Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype

Q39685564

CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses

Q40290840

New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy

Q40565584

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

Q40865054

A human CD4+ T-cell line expresses functional CD64 (Fc gamma RI), CD32 (Fc gamma RII), and CD16 (Fc gamma RIII) receptors but these do not enhance the infectivity of HIV-1-IgG complexes

Q41141456

The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut.

Q43095069

Human T cells that are able to produce IL-17 express the chemokine receptor CCR6.

Q45054355

Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART.

Q47150484

P275

Creative Commons Attribution 4.0 International

copyrighted

issue

language of work or name

English

Q1860

P304

page(s)

15541

P577

publication date

2018-10-19

P1433

published in

Scientific Reports

Q2261792

P1476

title

CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control

P478

volume

Reverse relations

cites work (P2860)

Q91983859	HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood
Q92436551	Review: HIV-1 phylogeny during suppressive antiretroviral therapy
Q92300043	Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs